3.9 Article

Single session of brief electrical stimulation immediately following crush injury enhances functional recovery of rat facial nerve

期刊

出版社

JOURNAL REHAB RES & DEV
DOI: 10.1682/JRRD.2011.03.0033

关键词

electrical stimulation; facial nerve; facial paralysis; functional recovery; injury; motoneuron; peripheral nerve; regeneration; repair; therapy

资金

  1. Research Funding Committee at Loyola University [200374]
  2. Department of Veterans Affairs Rehabilitation Research and Development Service [CDA-2 RRD B6598W]

向作者/读者索取更多资源

Peripheral nerve injuries lead to a variety of pathological conditions, including paresis or paralysis when the injury involves motor axons. We have been studying ways to enhance the regeneration of peripheral nerves using daily electrical stimulation (ES) following a facial nerve crush injury In our previous studies, ES was not initiated until 24 h after injury The current experiment tested whether ES administered immediately following the crush injury would further decrease the time for complete recovery from facial paralysis. Rats received a unilateral facial nerve crush injury and an electrode was positioned on the nerve proximal to the crush site. Animals received daily 30 min sessions of ES for 1 d (day of injury only), 2 d, 4 d, 7 d, or daily until complete functional recovery. Untreated animals received no ES. Animals were observed daily for the return of facial function. Our fmdings demonstrated that one session of ES was as effective as daily stimulation at enhancing the recovery of most functional parameters. Therefore, the use of a single 30 min session of ES as a possible treatment strategy should be studied in human patients with paralysis as a result of acute nerve injuries.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.9
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Geriatrics & Gerontology

How Should Cognitive Impairment Be Recognized?

Keith N. Fargo, Cyndy B. Cordell, Maria C. Carrillo

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2015)

Article Geriatrics & Gerontology

Brain Health: The Importance of Recognizing Cognitive Impairment: An IAGG Consensus Conference

John E. Morley, John C. Morris, Marla Berg-Weger, Soo Borson, Brian D. Carpenter, Natalia del Campo, Bruno Dubois, Keith Fargo, L. Jaime Fitten, Joseph H. Flaherty, Mary Ganguli, George T. Grossberg, Theodore K. Malmstrom, Ronald D. Petersen, Carroll Rodriguez, Andrew J. Saykin, Philip Scheltens, Eric G. Tangalos, Joe Verghese, Gordon Wilcock, Bengt Winblad, Jean Woo, Bruno Vellas

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2015)

Article Neurosciences

Electrical stimulation and testosterone enhance recovery from recurrent laryngeal nerve crush

Gina N. Monaco, Todd J. Brown, Ryan C. Burgette, Keith N. Fargo, Lee M. Akst, Kathryn J. Jones, Eileen M. Foecking

RESTORATIVE NEUROLOGY AND NEUROSCIENCE (2015)

Editorial Material Clinical Neurology

The crisis in recruitment for clinical trials in Alzheimer's and dementia: An action plan for solutions

Keith N. Fargo, Maria C. Carrillo, Michael W. Weiner, William Z. Potter, Zaven Khachaturian, George Vradenburg, Michael W. Weiner

ALZHEIMERS & DEMENTIA (2016)

Article Neurosciences

Bupivacaine increases the rate of motoneuron death following peripheral nerve injury

Susanna C. Byram, Scott W. Byram, Nicholas M. Miller, Keith N. Fargo

RESTORATIVE NEUROLOGY AND NEUROSCIENCE (2017)

Article Clinical Neurology

Patient and Caregiver Assessment of the Benefits From the Clinical Use of Amyloid PET Imaging

Rafid Mustafa, Jared R. Brosch, Gil D. Rabinovici, Bradford C. Dickerson, Maria C. Carrillo, Bradley S. Glazier, Sujuan Gao, Martha Tierney, Keith N. Fargo, Mary G. Austrom, Susan De Santi, David G. Clark, Liana G. Apostolova

ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2018)

Editorial Material Clinical Neurology

2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease

Keith N. Fargo, Paul Aisen, Marilyn Albert, Rhoda Au, Maria M. Corrada, Steven DeKosky, David Drachman, Howard Fillit, Laura Gitlin, Magali Haas, Karl Herrup, Claudia Kawas, Ara S. Khachaturian, Zaven S. Khachaturian, William Klunk, David Knopman, Walter A. Kukull, Bruce Lamb, Rebecca G. Logsdon, Paul Maruff, Marsel Mesulam, William Mobley, Richard Mohs, David Morgan, Ralph A. Nixon, Steven Paul, Ronald Petersen, Brenda Plassman, William Potter, Eric Reiman, Barry Reisberg, Mary Sano, Rachel Schindler, Lon S. Schneider, Peter J. Snyder, Reisa A. Sperling, Kristine Yaffe, Lisa J. Bain, William H. Thies, Maria C. Carrillo

ALZHEIMERS & DEMENTIA (2014)

Article Otorhinolaryngology

Outcomes of endoscopy and computed tomography in patients with chronic rhinosinusitis

Muhamad Amine, Lauren Lininger, Keith N. Fargo, Kevin C. Welch

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2013)

Article Clinical Neurology

Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need

Ganesh M. Babulal, Yakeel T. Quiroz, Benedict C. Albensi, Eider Arenaza-Urquijo, Arlene J. Astell, Claudio Babiloni, Alex Bahar-Fuchs, Joanne Bell, Gene L. Bowman, Adam M. Brickman, Gael Chetelat, Carrie Ciro, Ann D. Cohen, Peggye Dilworth-Anderson, Hiroko H. Dodge, Simone Dreux, Steven Edland, Anna Esbensen, Lisbeth Evered, Michael Ewers, Keith N. Fargo, Juan Fortea, Hector Gonzalez, Deborah R. Gustafson, Elizabeth Head, James A. Hendrix, Scott M. Hofer, Leigh A. Johnson, Roos Jutten, Kerry Kilborn, Krista L. Lanctot, Jennifer J. Manly, Ralph N. Martins, Michelle M. Mielke, Martha Clare Morris, Melissa E. Murray, Esther S. Oh, Mario A. Parra, Robert A. Rissman, Catherine M. Roe, Octavio A. Santos, Nikolaos Scarmeas, Lon S. Schneider, Nicole Schupf, Sietske Sikkes, Heather M. Snyder, Hamid R. Sohrabi, Yaakov Stern, Andre Strydom, Yi Tang, Graciela Muniz Terrera, Charlotte Teunissen, Debora Melo van Lent, Michael Weinborn, Linda Wesselman, Donna M. Wilcock, Henrik Zetterberg, Sid E. O'Bryant

ALZHEIMERS & DEMENTIA (2019)

Article Clinical Neurology

International drive to illuminate delirium: A developing public health blueprint for action

Ara S. Khachaturian, Kathleen M. Hayden, John W. Devlin, Lee A. Fleisher, Sarah Lenz Lock, Colm Cunningham, Esther S. Oh, Tamara G. Fong, Donna Marie Fick, Edward R. Marcantonio, Vijeth Iyengar, Kenneth Rockwood, George A. Kuchel, Roderic G. Eckenhoff, Alasdair M. J. MacLullich, Richard N. Jones, Daniel Davis, Patricia M. D'Antonio, Keith N. Fargo, Marilyn S. Albert, Jeff D. Williamson, Shari M. Ling, Joan Weiss, Jason Karlawish, Ronald C. Petersen, Dan G. Blazer, Zaven S. Khachaturian, Sharon K. Inouye

ALZHEIMERS & DEMENTIA (2020)

Article Clinical Neurology

Validation of online functiona measures in cognitively impaired older adults

Rachel L. Nosheny, Monica R. Camacho, Chengshi Jin, John Neuhaus, Diana Truran, Derek Flenniken, Miriam Ashford, Maria C. Carrillo, Keith N. Fargo, James Hendrix, Lucy Hanna, Gil Rabinovici, Paul Maruff, R. Scott Mackin, Michael W. Weiner

ALZHEIMERS & DEMENTIA (2020)

Review Clinical Neurology

Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel

Claudio Babiloni, Xianghong Arakaki, Hamed Azami, Karim Bennys, Katarzyna Blinowska, Laura Bonanni, Ana Bujan, Maria C. Carrillo, Andrzej Cichocki, Jaisalmer de Frutos-Lucas, Claudio Del Percio, Bruno Dubois, Rebecca Edelmayer, Gary Egan, Stephane Epelbaum, Javier Escudero, Alan Evans, Francesca Farina, Keith Fargo, Alberto Fernandez, Raffaele Ferri, Giovanni Frisoni, Harald Hampel, Michael G. Harrington, Vesna Jelic, Jaeseung Jeong, Yang Jiang, Maciej Kaminski, Voyko Kavcic, Kerry Kilborn, Sanjeev Kumar, Alice Lam, Lew Lim, Roberta Lizio, David Lopez, Susanna Lopez, Brendan Lucey, Fernando Maestu, William J. McGeown, Ian McKeith, Davide Vito Moretti, Flavio Nobili, Giuseppe Noce, John Olichney, Marco Onofrj, Ricardo Osorio, Mario Parra-Rodriguez, Tarek Rajji, Petra Ritter, Andrea Soricelli, Fabrizio Stocchi, Ioannis Tarnanas, John Paul Taylor, Stefan Teipel, Federico Tucci, Mitchell Valdes-Sosa, Pedro Valdes-Sosa, Marco Weiergraeber, Gorsev Yener, Bahar Guntekin

Summary: The Electrophysiology Professional Interest Area and Global Brain Consortium endorsed recommendations on EEG measures for Alzheimer's disease clinical trials, emphasizing the need for standardized measurement methods and international collaboration.

ALZHEIMERS & DEMENTIA (2021)

Article Clinical Neurology

The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology

Liana G. Apostolova, Paul Aisen, Ani Eloyan, Anne Fagan, Keith N. Fargo, Tatiana Foroud, Constantine Gatsonis, Lea T. Grinberg, Clifford R. Jack, Joel Kramer, Robert Koeppe, Walter A. Kukull, Melissa E. Murray, Kelly Nudelman, Malia Rumbaugh, Arthur Toga, Prashanthi Vemuri, Amy Trullinger, Leonardo Iaccarino, Gregory S. Day, Neill R. Graff-Radford, Lawrence S. Honig, David T. Jones, Joseph Masdeu, Mario Mendez, Erik Musiek, Chiadi U. Onyike, Emily Rogalski, Steve Salloway, David A. Wolk, Thomas S. Wingo, Maria C. Carrillo, Bradford C. Dickerson, Gil D. Rabinovici

Summary: The Longitudinal EOAD Study (LEADS) aims to track EOAD patients, define their clinical, imaging, and fluid biomarker characteristics, develop sensitive cognitive and biomarker measures for future use, and establish a trial-ready network to advance Alzheimer's disease research.

ALZHEIMERS & DEMENTIA (2021)

Article Clinical Neurology

Committee on High-quality Alzheimer's Disease Studies (CHADS) consensus report

Greg A. Jicha, Erin L. Abner, Steven E. Arnold, Maria C. Carrillo, Hiroko H. Dodge, Steven D. Edland, Keith N. Fargo, Howard H. Feldman, Larry B. Goldstein, James Hendrix, Ruth Peters, Julie M. Robillard, Lon S. Schneider, Jodi R. Titiner, Christopher J. Weber

Summary: Consensus guidance has been developed for the development and conduct of high-quality Alzheimer's disease clinical trials, covering aspects such as scientific justification, trial registration, conflict of interest disclosure, and defined trial population. This guidance aims to assist in protocol development and may also support the education of potential trial participants and the public on appropriate clinical trial participation decisions.

ALZHEIMERS & DEMENTIA (2022)

暂无数据